Company profile for Jemincare

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Jemincare Group Co., Ltd. was founded in 1999. Its pharmaceutical history can be traced back to the 1950s with 12,000 employees. Its headquarters is located in Nanchang, China. It has many industrial platforms and R&D institutes in Jiangxi, Beijing, Shanghai, Jiangsu and Zhejiang. In 2017, the group’s revenue exceeded 23.7 billion yuan, ranked the sixth in the top 100 of Chinese pharmacy industry and the tenth in the top 100...
Jemincare Group Co., Ltd. was founded in 1999. Its pharmaceutical history can be traced back to the 1950s with 12,000 employees. Its headquarters is located in Nanchang, China. It has many industrial platforms and R&D institutes in Jiangxi, Beijing, Shanghai, Jiangsu and Zhejiang. In 2017, the group’s revenue exceeded 23.7 billion yuan, ranked the sixth in the top 100 of Chinese pharmacy industry and the tenth in the top 100 of Chinese medical industry. In according to innovation-driven strategies, Jemincare focus on R&D, production and market of modern Chinese medicine, biological agents, health care products.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
China
Address
Address
nanchang, jiangxi
Telephone
Telephone
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2025/10/19/3169017/0/en/RAPT-Therapeutics-to-Report-Topline-Data-from-Phase-2-Clinical-Trial-of-RPT904-in-Chronic-Spontaneous-Urticaria-CSU.html

GLOBENEWSWIRE
19 Oct 2025

https://www.fiercebiotech.com/biotech/rapt-re-rolls-after-flameout-paying-35m-challenger-novartis-roche-drug

FIERCE BIOTECH
24 Dec 2024

https://www.biospace.com/article/genentech-partners-with-chinese-biopharma-for-prostate-cancer-androgen-receptor-degrader/

Vanessa Doctor BIOSPACE
19 Aug 2022

https://www.prnewswire.com/news-releases/jemincare-announces-exclusive-license-agreement-with-genentech-to-develop-and-commercialize-novel-oral-androgen-receptor-degrader-301608317.html

PRNEWSWIRE
17 Aug 2022

https://www.biospectrumasia.com/news/25/20241/orion-partners-with-jemincare-for-novel-non-opioid-drug-candidate-for-pain-treatment.html

BIOSPECTRUMASIA
07 May 2022

https://www.prnewswire.com/news-releases/le-groupe-jemincare-a-termine-l-essai-clinique-de-phase-i-de-son-anticorps-neutralisant-anti-sars-cov-2-le-jmb2002--846114416.html

PRNEWSWIRE
14 Sep 2021

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty